Skip to content

Resilience improvement for pediatric blood cancer survivors

Development and effect of resilience improvement for pediatric blood cancer survivors

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008307
Enrollment
60
Registered
2023-03-17
Start date
2021-09-01
Completion date
Unknown
Last updated
2023-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Resilience improvement program) : 1) The experience of pediatric cancer survivors (3 min, motion graphics ) 2) Education program for life adaptation after treatments (20 min. Online lecture) 3)

Sponsors

The Catholic University of Korea
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Blood cancer survivors who visiting hospital after receiving final consolidation therapy, maintenance therapy, or bone marrow transplantation. Adolescents and young adults (14-20 years) Subject who voluntarily agreed to participate in the study

Exclusion criteria

Exclusion criteria: Adolescents and young adults with poor cognitive ability or difficulty in communication due to complications.

Design outcomes

Primary

MeasureTime frame
Resilience;Quality of life

Secondary

MeasureTime frame
Cancer survivors' self-efficacy

Countries

Korea, Republic of

Contacts

Public ContactSunhee Lee

The Catholic University of Korea

shlee418@catholic.ac.kr+82-2-3147-8440

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026